ABT
63
-2
CF
53
2
AIZ
66
-3
IRM
52
6
V
66
14
PAYX
53
2
KO
55
-12
DLTR
54
2
TXN
55
3
NEM
63
-2
EBAY
47
2
FSLR
47
3
PBI
52
2
PHM
48
-4
LOW
55
2
CMCSA
52
4
AIG
68
-4
CHRW
59
-3
GLW
53
3
TGT
50
3
ABT
63
-2
CF
53
2
AIZ
66
-3
IRM
52
6
V
66
14
PAYX
53
2
KO
55
-12
DLTR
54
2
TXN
55
3
NEM
63
-2
EBAY
47
2
FSLR
47
3
PBI
52
2
PHM
48
-4
LOW
55
2
CMCSA
52
4
AIG
68
-4
CHRW
59
-3
GLW
53
3
TGT
50
3
Financhill
Back

Summit Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58

SMMT
Summit Therapeutics

Last Price:
$23.50
Seasonality Move:
12.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Summit Therapeutics Stock Forecast

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 98.7% based on the past 10 years of stock performance.
  • Summit Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Summit Therapeutics Stock Undervalued?
    The current Summit Therapeutics [SMMT] share price is $23.47. The Score for SMMT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SMMT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 98.7% based on the past 10 years of stock performance.

Summit Therapeutics Stock Rating

Buy
58
Summit Therapeutics (SMMT) is a Buy

Is Summit Therapeutics overpriced?

  • Summit Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Summit Therapeutics Stock Price History

Is SMMT stock going to rise?

  • The current trend is moderately bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com

52-Week Data

52-Week High:
36.91
52-Week Low:
2.10

Prediction Charts

Market Cap:
17.3B
Price in USD:
23.47
Volume:
24.7M
Beta:
-0.17

Technical Analysis

SMA50:
21.08
SMA100:
20.21
SMA200:
18.37
52-Wk Change:
560.99%

Stock Predictions

  • Is Summit Therapeutics stock public?
    Yes, Summit Therapeutics is a publicly traded company.
  • What is the Summit Therapeutics stock quote today?
    The Summit Therapeutics stock price is 23.47 USD today.
  • How to buy Summit Therapeutics stock online?
    You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 16.01 17.32 18.90 15.55
Apr-8 18.10 16.64 18.10 16.20
Apr-9 16.33 18.23 18.90 15.78
Apr-10 17.77 20.15 21.25 17.76
Apr-11 20.24 23.24 23.31 20.16
Apr-14 23.97 26.13 26.23 22.84
Apr-15 26.01 24.62 26.23 23.23
Apr-16 24.00 23.05 24.60 22.21
Apr-17 22.96 24.61 24.99 22.86
Apr-21 24.43 25.22 25.47 24.25
Apr-22 25.69 27.35 27.54 25.52
Apr-23 29.95 33.23 33.85 28.56
Apr-24 33.00 36.70 36.91 32.48
Apr-25 34.48 23.47 35.92 22.22

Summit Therapeutics Earnings

Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics Forecast Revenue Growth

Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.14 per share.

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.